Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 969 | 1212 | 824 | 1140 | 1682 |
Fund Return | 8.51% | -3.05% | 21.21% | -6.26% | 2.66% | 5.34% |
Place in category | 66 | 66 | 66 | 63 | 33 | 2 |
% in Category | 84 | 84 | 84 | 85 | 54 | 12 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CDSPI S P 500 Index BlackRock | 121.3M | 26.83 | 12.28 | 14.21 | ||
CDSPI Global Growth Capital | 81.46M | 21.60 | 2.60 | 10.34 | ||
CDSPI Common Stock Fiera Capital | 42.79M | 17.02 | 10.33 | 9.50 | ||
CDSPI Moderate Growth Portfolio CI | 25.18M | 15.96 | 5.51 | 6.87 | ||
CDSPI Conservative Growth Portfolio | 19.84M | 14.50 | 4.68 | 6.15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
RBC European Equity Fund D | 6.75B | 8.22 | 3.90 | 7.21 | ||
RBC European Mid-Cap Equity Fund D | 1.68B | 7.55 | -4.19 | - | ||
Investors European Mid Cap Equity B | 1.09B | 10.30 | -1.60 | 5.53 | ||
Investors European Mid Cap Equity C | 1.09B | 10.00 | -1.82 | 5.31 | ||
Investors European Mid Cap Equity U | 1.09B | 11.74 | -0.06 | 7.16 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 4.71 | 750.9 | +4.03% | |
Investor B | SE0015811963 | 3.62 | 298.5 | +0.54% | |
ASML Holding | NL0010273215 | 3.22 | 642.10 | +1.68% | |
Relx | GB00B2B0DG97 | 3.18 | 3,723.00 | +3.04% | |
Gedeon Richter | HU0000123096 | 2.96 | 10,680.0 | -1.20% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review